[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Pages 71473-71474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27953]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-572]
Importer of Controlled Substances Application: Siegfried USA, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before January 27, 2020.
Such persons may also file a written request for a hearing on the
application on or before January 27, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on November 6, 2019, Siegfried USA, LLC, 33 Industrial
Park Road, Pennsville, New Jersey 08070 applied to be registered as an
importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Opium, raw............................. 9600 II
Poppy Straw Concentrate................ 9670 II
------------------------------------------------------------------------
[[Page 71474]]
The company plans to import the listed controlled substances to
manufacture bulk active pharmaceutical ingredients (API) for
distribution to its customers.
Dated: December 10, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-27953 Filed 12-26-19; 8:45 am]
BILLING CODE 4410-09-P